Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458907 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
A NA study, sponsored by P+F Products + Features USA.
- Not yet
- Registry status
- NA
- Development phase
- 780
- Enrollment target
NCT06458907 is a NA study that has not yet begun recruiting, run by P+F Products + Features USA. The registered enrollment target is 780 participants.
The verdict
NCT06458907, a NA study, has not yet begun recruiting, sponsored by P+F Products + Features USA.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 780 participants
- Enrollment target
Study Summary
Pivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.
Interventions
- DEVICE TricValve System
- DRUG Optimal medical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2026-08 |
| Est. Completion | 2032-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06458907
The ClinicalTrials.gov registry entry for NCT06458907 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is P+F Products + Features USA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which TricValve System is the first listed.
NCT06458907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06458907 about?
NCT06458907 is a clinical study titled "A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.". Pivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.
What is the current status of trial NCT06458907?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 780 participants. The study started on 2026-08. Estimated completion is 2032-11.
What interventions are being tested in trial NCT06458907?
The interventions under investigation include: TricValve System (DEVICE), Optimal medical therapy (DRUG).
Who is sponsoring clinical trial NCT06458907?
This trial is sponsored by P+F Products + Features USA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.